Article Text
PDFMe and my neurological illness
Charles Bonnet syndrome
Statistics from Altmetric.com
Footnotes
Funding The author has not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Patient consent Not required.
Provenance and peer review Commissioned. Externally peer reviewed by Christian Lueck, Canberra, Australia.
Correction notice This article has been updated since it was published online first. The author affiliation information has been updated.
Linked Articles
Read the full text or download the PDF:
Other content recommended for you
- Visual hallucinations in neurological and ophthalmological disease: pathophysiology and management
- Benefit of psychiatric evaluation on anxiety in patients with Charles Bonnet syndrome
- Visual hallucinations
- Charles Bonnet syndrome in patients with Stargardt disease: prevalence and risk factors
- Charles Bonnet syndrome in Asian patients in a tertiary ophthalmic centre
- Charles Bonnet syndrome in patients with glaucoma and good acuity
- Visual hallucinations and sight loss in children and young adults: a retrospective case series of Charles Bonnet syndrome
- Exacerbation of visual hallucinations in Charles Bonnet syndrome due to the social implications of COVID-19
- Negative outcome Charles Bonnet Syndrome
- Visual hallucinations in Parkinson's disease: a review and phenomenological survey